Strategic Expansion ProCure is an early mover in the NJ/NY tri-state region as the first proton therapy center, suggesting potential sales opportunities around partnerships, referral networks, and expanded service lines to capitalize on their established regional presence.

Technology Leadership With Pencil Beam Scanning (PBS) as a core differentiator for advanced tumor treatment, there is a opportunity to offer complementary imaging, treatment planning software, or remote monitoring solutions that integrate with their PBS workflow.

Patient Throughput Having treated over 7,000 patients indicates a high-volume facility that may benefit from optimized operations, scheduling optimization, patient engagement platforms, and billing optimization to boost efficiency and patient experience.

Financial Scale Revenue range and substantial funding suggest capacity for high-value partnerships, capital equipment financing, and managed service agreements for IT, security, and clinical data analytics applications.

Care Continuum As a specialized cancer care provider, ProCure could be receptive to partnerships in research, clinical trial support, treatment outcomes analytics, and multi-site care coordination to extend value across networks and patient populations.